FFUND is proud to have helped AMT Medical to get awarded EIC funding of €2.5m for their innovative project: ELANA®.
AMT Medical is a clinical-stage medical device company developing a highly innovative and unique heart bypass system. The team around CEO Rutger Tulleken has one dream: to banish open-heart bypass surgery from the world.
What is the project about?
The ELANA® heart bypass procedure enables surgery on the beating heart via a suturing-free procedure. The goal is to minimize long recovery times and serious complications for heart patients, allowing them to quickly go home and do the things they enjoy without pain or dysfunction. With the EIC Accelerator award, AMT Medical has obtained the financial resources to clinically test the ELANA® heart bypass in a minimally invasive procedure. If successful, heart surgery can be performed through keyholes rather than through opening the ribcage. CEO Rutger Tulleken: “Each year, a million patients need a bypass operation and many cardiac surgeons are following us closely because they need a safe and faster alternative to open-heart surgery. We will make it happen!”
How did FFUND help?
“Our company and project were eligible for the EIC program, but FFUND and its experts in different areas helped us to create a perfect proposal,” Tulleken explains. “This meant that we could submit a perfectly presentable, financially sound, complete, and well-laid-out plan, which was rewarded.”
Katja Jansen, consultant FFUND says: “I am amazed by the technology behind the ELANA® bypass system, and by the drive of each team member at AMT Medical. I truly believe that they have what it takes to revolutionize the way heart surgery is performed and I am excited to follow their progress.”
Read more in the article about the highlights & lessons learned of AMT Medical.
